BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,988,000 | +53.6% | 26,380 | +48.0% | 0.01% | +57.1% |
| Q2 2022 | $2,597,000 | +164.5% | 17,820 | +24.1% | 0.01% | +133.3% |
| Q1 2021 | $982,000 | -24.5% | 14,364 | -5.3% | 0.00% | -40.0% |
| Q4 2020 | $1,300,000 | -21.0% | 15,167 | -41.8% | 0.01% | -37.5% |
| Q3 2020 | $1,645,000 | +29.5% | 26,040 | +50.0% | 0.01% | 0.0% |
| Q2 2020 | $1,270,000 | +12.7% | 17,360 | -42.1% | 0.01% | 0.0% |
| Q3 2018 | $1,127,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |